Active	Status	Sponsor type	Region	Phase	Filter
5 Active 0 Inactive 5 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other Show only owner-sponsored trials	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

5 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
lumateperone deuterated (ITI-1284 ODT-SL) / Intra-Cellular Therapies
ITI-1284-301, NCT06480383: Study of ITI-1284 as an Adjunctive Treatment in Patients With Generalized Anxiety Disorder	Recruiting	2	705	US	ITI-1284 10 mg, ITI-1284 20 mg, Placebo	Intra-Cellular Therapies, Inc.	Generalized Anxiety Disorder	06/27	06/27
NCT06540833: A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Psychosis Associated With Alzheimer's Disease	Recruiting	2	370	US	ITI-1284, Placebo	Intra-Cellular Therapies, Inc.	Psychosis Associated With Alzheimer's Disease	09/27	10/27
ITI-1284-101, NCT06651567: A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Agitation Associated With Alzheimer's Dementia	Recruiting	2	320	US	ITI-1284, Placebo	Intra-Cellular Therapies, Inc.	Agitation Associated With Alzheimer's Dementia	10/27	11/27
NCT06701903: Study of ITI-1284 as Monotherapy Treatment in Patients With Generalized Anxiety Disorder	Recruiting	2	570	US	ITI-1284 10 mg, ITI-1284 20 mg, Placebo	Intra-Cellular Therapies, Inc.	Generalized Anxiety Disorder	06/27	06/27
NCT06299410: PET Study to Evaluate Brain Receptor Occupancy, Safety and Pharmacokinetics of ITI-1284 in Healthy Subjects	Recruiting	1	30	US	ITI-1284 10 mg, ITI-1284 20 mg	Intra-Cellular Therapies, Inc.	Healthy Volunteers	09/25	09/25